Residents’ Corner

The Lowdown on Low-Dose Naltrexone

Author and Disclosure Information

 

References

How to Monitor

The following monitoring information is adapted from the practice of Apple Bodemer, MD, a board-certified dermatologist at the University of Wisconsin (Madison, Wisconsin) who also is fellowship trained in integrative medicine.

There is a paucity of published data about LDN dosing for inflammatory skin diseases. However, prescribers should be aware that LDN can alter thyroid hormone levels, especially in patients with autoimmune thyroid disease. If a thyroid-stimulating hormone (TSH) level within reference range has not been noted in the last year, consider screening with a TSH test and also assessing for a personal or family history of thyroid disease. If the TSH level is within reference range, there generally is no need to monitor while treating with LDN. Consider checking TSH levels every 4 months in patients with thyroid disease while they are on LDN therapy and be sure to educate them about symptoms of hyperthyroidism.

Side Effects

Low-dose naltrexone has a minimal side-effect profile with self-limited side effects that often resolve within approximately 1 week. One of the most commonly reported side effects is sleep disturbance with vivid dreams, which has been reported in 37% of participants.1 If your patients experience this side effect, you can reassure them that it improves with time. You also can switch to morning dosing to try and alleviate sleep disturbances at night. Another possible side effect is gastrointestinal tract upset. Importantly, there is no known abuse potential for LDN.1 To stop LDN, patients should be stable for 6 to 12 months, and there is no need to wean them off it.

Cost and Availability

Because use of LDN in dermatology is considered off label and it is not approved by the US Food and Drug Administration to treat any medical conditions, it must be prescribed through a compounding pharmacy, usually without insurance coverage. The monthly cost is approximately $30 depending on the pharmacy (unpublished data), which may be cost prohibitive for patients, so it is important to counsel them about price before starting treatment.

Final Thoughts

Low-dose naltrexone is an alternative treatment option that can be considered in patients with inflammatory skin diseases. It has a favorable side-effect profile, especially compared to other systemic anti-inflammatory agents; however, additional studies are needed to learn more about its safety and efficacy. If patients ask you about LDN, the information provided here can guide you with how it works and how to prescribe it.

Pages

Recommended Reading

Pediatric dermatology update: New research offers insight into psoriasis, alopecia
MDedge Dermatology
Certolizumab safety profile varies widely across indications
MDedge Dermatology
FDA approves infliximab-axxq for numerous indications
MDedge Dermatology
Depression and Suicidality in Psoriasis and Clinical Studies of Brodalumab: A Narrative Review
MDedge Dermatology
Repeat LTBI testing best in patients taking biologics with new risk factors
MDedge Dermatology
Verrucous Psoriasis Treated With Methotrexate and Acitretin Combination Therapy
MDedge Dermatology
Ultrasound improves specificity of psoriatic arthritis referrals
MDedge Dermatology
Meta-analysis provides safety data on IL-17, IL-23 inhibitors
MDedge Dermatology
The Ketogenic Diet and Dermatology: A Primer on Current Literature
MDedge Dermatology
Bimekizumab elevates psoriasis therapy
MDedge Dermatology